Cheaper liver dialysis machine could be just as effective

NCT ID NCT02310542

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares two machines that clean the blood of toxins when the liver fails: MARS (a standard system) and SPAD (a simpler, cheaper alternative). Thirty-four patients with severe liver failure will try both machines in random order. The goal is to see if SPAD works as well as MARS at removing bilirubin and other toxins.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

albumin dialysis (MARS or SPAD device)

What this could lead to

If one system works as well as the other, it could offer a simpler, less expensive way to support liver function in critically ill patients.

What could go wrong

This is a small, early-stage study with only 34 participants, so results may not apply broadly. Both systems are temporary supports, not cures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER FAILURE, ACUTE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute liver failure chronic liver failure End Stage Liver Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital de la Croix Rousse - Service de réanimation chirurgicale

    Lyon, 69317, France